These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 1227911)
21. Comparison of phencyclidine, etoxadrol and dexoxadrol in the pigeon. Leander JD Subst Alcohol Actions Misuse; 1982; 3(4):197-203. PubMed ID: 6132451 [TBL] [Abstract][Full Text] [Related]
22. [Interference of the action of dimethyl-2,2-hydroxymethyl-4 dioxolane- 1,3 (AG) with various active pharmacomolecules on the central nervous system]. Cheav SL; Ziade FF; Foussard-Blanpin O Ann Pharm Fr; 1987; 45(6):445-51. PubMed ID: 3504119 [No Abstract] [Full Text] [Related]
23. Distribution and elimination of RGH-5002 in rats. Terjéki E; Pátfalusi M; Trafikánt G; Kapás M Acta Physiol Hung; 1995; 83(2):143-50. PubMed ID: 8588501 [TBL] [Abstract][Full Text] [Related]
24. Physiological pharmacokinetics of a new muscle-relaxant, inaperisone, combined with its pharmacological effect on blood flow rate. Nagata O; Murata M; Kato H; Terasaki T; Sato H; Tsuji A Drug Metab Dispos; 1990; 18(6):902-10. PubMed ID: 1981535 [TBL] [Abstract][Full Text] [Related]
25. [Pharmacokinetics of C14-olivomycin in the body of mice with lymphosarcoma (L10-1 strain)]. Vatin AE; Filatov PP Antibiotiki; 1975 Jan; 20(1):6-11. PubMed ID: 1173211 [TBL] [Abstract][Full Text] [Related]
26. Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats. Cossum PA; Sasmor H; Dellinger D; Truong L; Cummins L; Owens SR; Markham PM; Shea JP; Crooke S J Pharmacol Exp Ther; 1993 Dec; 267(3):1181-90. PubMed ID: 8166890 [TBL] [Abstract][Full Text] [Related]
27. [Biotransformation and pharmacokinetics of bamipine in rats. 2. Studies of the pharmacokinetics (1.)]. Neidlein VR; Kleiser M Arzneimittelforschung; 1987 Feb; 37(2):174-7. PubMed ID: 2883979 [TBL] [Abstract][Full Text] [Related]
28. Domiodol; separation of cis and trans isomers and comparison of their pharmacological activity. Riva M; Gentili P; Kogi K; Saito T; Cantarelli G; Ravenna F Arzneimittelforschung; 1983; 33(8):1091-3. PubMed ID: 6685484 [TBL] [Abstract][Full Text] [Related]
30. Tissue distribution and elimination of N-methyl-N-2,4,6-tetranitroaniline (tetryl) in rats. Myers SR; Spinnato JA Arch Toxicol; 2007 Dec; 81(12):841-8. PubMed ID: 17680234 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats. Sugimoto T; Hayashi T; Okita A; Morino A Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299 [TBL] [Abstract][Full Text] [Related]
32. Mechanism of control of skeletal-muscle contraction by dantrolene sodium. Ellis KO; Carpenter JF Arch Phys Med Rehabil; 1974 Aug; 55(8):362-9. PubMed ID: 4368898 [No Abstract] [Full Text] [Related]
33. Pharmacological studies of the new centrally acting muscle relaxant 4'-ethyl-2-methyl-3-pyrrolidinopropiophenone hydrochloride. Morikawa K; Oshita M; Yamazaki M; Ohara N; Mizutani F; Kato H; Ito Y; Kontani H; Koshiura R Arzneimittelforschung; 1987 Mar; 37(3):331-6. PubMed ID: 3593447 [TBL] [Abstract][Full Text] [Related]
34. NTP toxicity studies of carisoprodol (CAS No. 78-44-4) administered by Gavage to F344/N rats and B6C3F1 mice. Chan PC Toxic Rep Ser; 2000 Aug; (56):1-G14. PubMed ID: 11986679 [TBL] [Abstract][Full Text] [Related]
35. In vivo metabolism and final disposition of a novel nonsteroidal androgen in rats and dogs. Perera MA; Yin D; Wu D; Chan KK; Miller DD; Dalton J Drug Metab Dispos; 2006 Oct; 34(10):1713-21. PubMed ID: 16815963 [TBL] [Abstract][Full Text] [Related]
37. [Animal experiments on the pharmacokinetics of N alpha-tosyl-(3-amidinophenyl)alanine piperidide (TAPAP), a new thrombin inhibitor]. Hauptmann J; Markwardt F; Richter M Pharmazie; 1982 Jun; 37(6):430-3. PubMed ID: 7122685 [TBL] [Abstract][Full Text] [Related]
38. [Studies on spasmolytics. VI. Pharmacological studies of stereoisomeric 1,4-trans- and cis-4-benziloyloxy-1-(2,2-dimethyl-1,3-dioxolan-4-ylmet hyl)-1- methylpiperidinium compounds]. Kajiwara Y; Sugai S; Kanbara T; Naito Y; Kawada T; Kimura T; Kuriyama T; Katsuhara N; Terawaki Y; Kutsuma T Yakugaku Zasshi; 1985 Oct; 105(10):983-9. PubMed ID: 4093862 [No Abstract] [Full Text] [Related]
39. Assessing the plasma pharmacokinetics, tissue distribution, excretion and effects on cholesterol pharmacokinetics of a novel hydrophilic compound, FM-VP4, following administration to rats. Wasan KM; Peteherych KD; Najafi S; Zamfir C; Pritchard PH J Pharm Pharm Sci; 2001; 4(3):207-16. PubMed ID: 11737986 [TBL] [Abstract][Full Text] [Related]
40. Metabolism, excretion, and pharmacokinetics of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid, an EP2 receptor-selective prostaglandin E2 agonist, in male and female Sprague-Dawley rats. Johnson KA; Prakash C Drug Metab Dispos; 2005 Aug; 33(8):1191-201. PubMed ID: 15886349 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]